AzTrials
AzTrials

Open Burn Pit ExposureNCT06305091

DNA Methylation Markers in Veterans Exposed to Open Burn Pits

An observational study of Open Burn Pit Exposure, run by Central Arkansas Veterans Healthcare System at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Background: The VA and DoD estimate that 3.5 million Veterans and Service Members were exposed to open burn pits used for waste disposal during military deployments to countries such as Kuwait, Afghanistan, and Iraq since 1990. Read more about this study

Who is it for?
Ages 25 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Open Burn Pit Exposure
What is being tested?
Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples
How many people
330 participants
Where
1 siteUnited States
Study dates
13 Mar 2023to 31 Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Veterans aged 25- 70 years

Who may be able to join

  • Age 25-70 years
  • Participants that reside in Arkansas
  • All Veterans that are deployed
  • Participants registered in the AHOBPR burn pit registry mainly for exposed Veterans. However, unexposed participants from the registry could also be included.
  • Participants not listed in the AHOBPR burn pit registry mainly for unexposed Veterans. However, exposed participants not from the registry could also be included.
  • Non-smokers: defined as smoke less than 10 cigarettes during lifetime.
  • Fluent in English

Who cannot join

  • Any occupation and/or hobbies involves diesel exhaust, welding, paint, or other chemical fumes or organic dust
  • Any use of tobacco or nicotine products within the past year, such as smoking (cigarettes, pipes, cigars, e-cigarettes, vaping devices)
  • Self-report and/or chart review that patient is pregnant
  • Self-report and/or chart review that patient weight is less than 110 lbs
  • Participants whom the PI deems to be otherwise ineligible

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kalpana Padala, MD, MS contact

501-257-2044

kalpana.padala@va.gov

Trent Trice, BS contact

501-257-2403

trent.trice@va.gov

United States1 site, 1 recruiting
  • Central Arkansas Veterans Healthcare System (3J/NLR)

    North Little Rock, Arkansas, 72114

    Kalpana Padala, MD, 501-257-2044, kalpana.padala@va.gov

    Trent Trice, BS, 501-257-2403, trent.trice@va.gov

    Recruiting

Other trials in United States

About this study

Official title: DNA Methylation Markers Associated With Exposure and Adverse Health Outcomes in Veterans Exposed to Airborne Hazards From Open Burn Pits

Background: The VA and DoD estimate that 3.5 million Veterans and Service Members were exposed to open burn pits used for waste disposal during military deployments to countries such as Kuwait, Afghanistan, and Iraq since 1990. Since the lasting adverse effects of this exposure on health are unknown, the VA Airborne Hazards and Open Burn Pit Registry (AHOBPR) was created. More than 209,000 participants to date have answered the registry questionnaire about the extent of exposure to burn pits and other airborne hazards. The questions attempted to quantify the duration of exposure, the severity of acute health effects, and the relative timing of onset or worsening of chronic respiratory, cardiovascular, neurological, and other illnesses. However, the AHOBPR interview lacks specific inquiry about mental health and biomarkers. The proposed study will recruit AHOBPR participants and non-participant for a follow-up enhanced evaluation of their health in a translational research study to better characterize their psychological, physical health profile, and potentially harmful epigenetic and biochemical exposure-related alterations.

Hypothesis: The investigators hypothesize that 1) the severity of individual exposure to burn pits will be positively correlated with levels of persistent organic pollutants in blood and metals in urine and specific epigenetic alterations in DNA methylation; and 2) levels of toxic chemicals and alterations in the methylation of specific genes will be positively correlated with chronic problems involving the cardiovascular, respiratory, neuropsychiatric and other systems.

Read more

Specific Aims: (1) Describe and quantify relationships of the intensity and duration of exposure with persistent organic chemicals/metals in the registry participants and ascertain their relationships with health outcomes linked to burn pit exposure. (2) Discover and validate DNA methylation marks that best distinguish between individuals exposed to burn pits and those not; then describe and quantify the relationships between DNA methylation, intensity and duration of exposure, and health outcomes. Completion of these aims will allow quantitation of the relationships between toxic chemicals, DNA methylation, and individual health problems.

Study Design: A clinical study will be conducted at the Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences. The AHOBPR registry and non-specific recruitment will be used to enroll OBP exposed (N=220) and age and gender-matched unexposed (N=110) veterans. The unexposed veterans will be given the same questions as in the AHOBPR to determine their open burn pit exposure status with a confirmation of no exposure. A single study visit per participant will strengthen the registry by validating its contents using the electronic patient record and adding new study data on physical and mental function, including effects of epigenetic and toxicant measures obtained from blood and urine samples. Linear and logistic regression modeling will be used to determine the relationships described by the study aims while controlling for confounding variables and false discovery rates.

Long-term and Short-term Impact on Patient Populations: The immediate goal of the study is to measure exposure-related differences in levels of potentially toxic chemicals present in blood and urine and differences in DNA methylation. The study will then determine the relationships between exposure, the biochemical and molecular measures, and the presence of health problems. The value of this information is high since the effects of burn pit exposure are largely unknown but potentially serious. The longer-term goal for this line of investigation is to enable personalized and tailored health management for exposed individuals. The investigators believe that the biochemical and molecular measures may become novel biomarkers that enable the prediction of risk for disease and adverse disease outcomes such that preventative measures can be employed. Furthermore, the results will be highly relevant to other occupations in which exposure to airborne pollutants is high.

Being tested
Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples
Keywords
Open Burn Pits, toxic exposure, veterans

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samplesDiagnostic test

    Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples

Study groups in NCT06305091
Study groupRoleWhat they receive
OBP exposedVeterans exposed to Open Burn Pits (N=220)
Receives: Diagnostic Test: Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples
OBP not exposedVeterans not exposed to Open Burn Pits (N=110)
Receives: Diagnostic Test: Health survey for physical and mental health comorbidities, epigenetic marker and heavy metals in blood and urine samples

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. DNA methylation markers and heavy metals

    Measured: Day 1

Secondary outcomes (1)
  1. Physical and mental health comorbidities

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2024
  2. Study start13 Mar 2023
  3. Primary completion31 Mar 2027 (estimated)
  4. Study completion31 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
330 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06305091
Sponsor's protocol ID
1681559
Status last verified
Mar 2024
First submitted
4 Mar 2024
Last updated
12 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Open Burn Pit Exposure, run by Central Arkansas Veterans Healthcare System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kalpana Padala, MD, MS (501-257-2044, kalpana.padala@va.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

DNA methylation markers and heavy metals (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in